269 related articles for article (PubMed ID: 21881879)
1. Novel therapies in MM: from the aspect of preclinical studies.
Hideshima T; Anderson KC
Int J Hematol; 2011 Oct; 94(4):344-354. PubMed ID: 21881879
[TBL] [Abstract][Full Text] [Related]
2. Novel targets and derived small molecule inhibitors in multiple myeloma.
Podar K
Curr Cancer Drug Targets; 2012 Sep; 12(7):797-813. PubMed ID: 22671928
[TBL] [Abstract][Full Text] [Related]
3. The Role of Intracellular Signaling Pathways in the Pathogenesis of Multiple Myeloma and Novel Therapeutic Approaches.
Kizaki M; Tabayashi T
J Clin Exp Hematop; 2016; 56(1):20-7. PubMed ID: 27334854
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow microenvironment and the identification of new targets for myeloma therapy.
Podar K; Chauhan D; Anderson KC
Leukemia; 2009 Jan; 23(1):10-24. PubMed ID: 18843284
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
Shay G; Hazlehurst L; Lynch CC
J Mol Med (Berl); 2016 Jan; 94(1):21-35. PubMed ID: 26423531
[TBL] [Abstract][Full Text] [Related]
6. Contemporary drug therapies for multiple myeloma.
de la Puente P; Azab AK
Drugs Today (Barc); 2013 Sep; 49(9):563-73. PubMed ID: 24086952
[TBL] [Abstract][Full Text] [Related]
7. Emerging strategies for targeting cell adhesion in multiple myeloma.
Nair RR; Gebhard AW; Emmons MF; Hazlehurst LA
Adv Pharmacol; 2012; 65():143-89. PubMed ID: 22959026
[TBL] [Abstract][Full Text] [Related]
8. Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma.
Abe M
Int J Hematol; 2011 Oct; 94(4):334-343. PubMed ID: 22005835
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies of novel targeted therapies.
Hideshima T; Anderson KC
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1071-91, viii-ix. PubMed ID: 17996589
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the treatment of Multiple Myeloma.
Yasui H; Hideshima T; Richardson PG; Anderson KC
Curr Pharm Biotechnol; 2006 Oct; 7(5):381-93. PubMed ID: 17076653
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab granted breakthrough drug status.
Laubach JP; Tai YT; Richardson PG; Anderson KC
Expert Opin Investig Drugs; 2014 Apr; 23(4):445-52. PubMed ID: 24555809
[TBL] [Abstract][Full Text] [Related]
12. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor therapy in multiple myeloma.
Chauhan D; Hideshima T; Mitsiades C; Richardson P; Anderson KC
Mol Cancer Ther; 2005 Apr; 4(4):686-92. PubMed ID: 15827343
[TBL] [Abstract][Full Text] [Related]
14. Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma.
Palumbo A; Sonneveld P
Expert Rev Hematol; 2015 Aug; 8(4):481-91. PubMed ID: 26070331
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapies for multiple myeloma.
Podar K; Tai YT; Hideshima T; Vallet S; Richardson PG; Anderson KC
Expert Opin Emerg Drugs; 2009 Mar; 14(1):99-127. PubMed ID: 19249983
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-myeloma agents and angiogenesis.
Anargyrou K; Dimopoulos MA; Sezer O; Terpos E
Leuk Lymphoma; 2008 Apr; 49(4):677-89. PubMed ID: 18398734
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
Podar K; Jager D
Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
[TBL] [Abstract][Full Text] [Related]
18. Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma.
Neri P; Bahlis NJ
Curr Cancer Drug Targets; 2012 Sep; 12(7):776-96. PubMed ID: 22671924
[TBL] [Abstract][Full Text] [Related]
19. Clinical update: novel targets in multiple myeloma.
Anderson KC
Semin Oncol; 2004 Dec; 31(6 Suppl 16):27-32; discussion 33. PubMed ID: 15799242
[TBL] [Abstract][Full Text] [Related]
20. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.
Hideshima T; Mitsiades C; Tonon G; Richardson PG; Anderson KC
Nat Rev Cancer; 2007 Aug; 7(8):585-98. PubMed ID: 17646864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
